Britain on Wednesday approved the Pfizer-BioNTech COVID-19 vaccine that will be rolled out from early next week.
Britain’s vaccine committee will decide which priority groups will get the jab first such as care home residents, health and care staff, the elderly and people who are clinically extremely vulnerable.
“The vaccine will be made available across the UK from next week.”
Both Pfizer-BioNTech and US biotech firm Moderna have reported preliminary findings of more than 90% effectiveness in trials based on new messenger RNA (mRNA) technology.
Pfizer said Britain’s emergency use authorization marks a historic moment in the fight against COVID-19.
“This authorization is a goal we have been working toward since we first declared that science will win, and we applaud the MHRA for their ability to conduct a careful assessment and take timely action to help protect the people of the UK,” said Pfizer CEO Albert Bourla.
“As we anticipate further authorizations and approvals, we are focused on moving with the same level of urgency to safely supply a high-quality vaccine around the world.”
A vaccine is seen as the best chance for the world to get back to some semblance of normality amid a global pandemic which has killed nearly 1.5 million people and upended the global economy.
- Sikkim logs 40 new COVID-19 cases, 1 fresh fatality
- Fixed-wing flight services to remote towns of Arunachal Pradesh
- PM urges people to ensure no one is left out of vaccination’s ‘circle of safety’
- Sikkim districts to undergo nomenclature change: CM Golay
- How this social entrepreneur is championing love for voiceless animals
- Assam: 5 of 6 accused deny charges of instigating Gorukhuti violence